Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
JCI Insight|September 10, 2024
Increased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polypsJunqin Bai, Atsushi Kato, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2024
Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissueNaruhito Iwasaki, Julie A Poposki, Aiko Oka, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2024
Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitisNaruhito Iwasaki, Julie A Poposki, Masanori Kidoguchi, et al.
Mucosal Immunology|October 24, 2019
Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polypsNoriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2021
Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesisWhitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 4, 2015
Clinical Consensus Statement: Septoplasty with or without Inferior Turbinate ReductionJoseph K Han, Scott P Stringer, Richard M Rosenfeld, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 7, 2022
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polypsJacob G Eide, Jeffanie Wu, Whitney W Stevens, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory diseaseToru Takahashi, Atsushi Kato, Sergejs Berdnikovs, et al.
Allergy and Asthma Proceedings|September 3, 2021
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitisGayatri B Patel, Elizabeth A Kudlaty, Amina Guo, et al.
Immunity, Inflammation and Disease|May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polypsJulie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
Pageof 12